The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Kidney Outcomes in Long COVID
Open accessAbstract
Significance Statement: Patients who survive coronavirus disease 2019 (COVID-19) are at higher risk of post-acute sequelae involving pulmonary and several extrapulmonary organ systems—generally referred to as long COVID. However, a detailed assessment of kidney outcomes in long COVID is not yet available. Here we show that, beyond the acute phase of illness, 30-day survivors of COVID-19 exhibited higher risks of AKI, eGFR decline, ESKD, major adverse kidney events (MAKE), and steeper longitudinal decline in eGFR. The risks of kidney outcomes increased according to the severity of the acute infection (categorized by care setting into non-hospitalized, hospitalized, and admitted to intensive care). The findings provide insight into the long-term consequences of COVID-19 on kidney outcomes and suggest that post-acute COVID-19 care should include attention to kidney function and disease. Background: COVID-19 is associated with increased risk of post-acute sequelae involving pulmonary and extrapulmonary organ systems—referred to as long COVID. However, a detailed assessment of kidney outcomes in long COVID is not yet available. Methods: We built a cohort of 1,726,683 US Veterans identified from March 1, 2020 to March 15, 2021, including 89,216 patients who were 30-day survivors of COVID-19 and 1,637,467 non-infected controls. We examined risks of AKI, eGFR decline, ESKD, and major adverse kidney events (MAKE). MAKE was defined as eGFR decline ≥50%, ESKD, or all-cause mortality. We used inverse probability–weighted survival regression, adjusting for predefined demographic and health characteristics, and algorithmically selected high-dimensional covariates, including diagnoses, medications, and laboratory tests. Linear mixed models characterized intra-individual eGFR trajectory. Results: Beyond the acute illness, 30-day survivors of COVID-19 exhibited a higher risk of AKI (aHR, 1.94; 95% CI, 1.86 to 2.04), eGFR decline ≥30% (aHR, 1.25; 95% CI, 1.14 to 1.37), eGFR decline ≥40% (aHR, 1.44; 95% CI, 1.37 to 1.51), eGFR decline ≥50% (aHR, 1.62; 95% CI, 1.51 to 1.74), ESKD (aHR, 2.96; 95% CI, 2.49 to 3.51), and MAKE (aHR, 1.66; 95% CI, 1.58 to 1.74). Increase in risks of post-acute kidney outcomes was graded according to the severity of the acute infection (whether patients were non-hospitalized, hospitalized, or admitted to intensive care). Compared with non-infected controls, 30-day survivors of COVID-19 exhibited excess eGFR decline (95% CI) of −3.26 (−3.58 to −2.94), −5.20 (−6.24 to −4.16), and −7.69 (−8.27 to −7.12) ml/min per 1.73 m 2 per year, respectively, in non-hospitalized, hospitalized, and those admitted to intensive care during the acute phase of COVID-19 infection. Conclusions: Patients who survived COVID-19 exhibited increased risk of kidney outcomes in the post-acute phase of the disease. Post-acute COVID-19 care should include attention to kidney disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 1×
“15 was taken as evidence of balance between the COVID-19 and VHA users group.(21,22) We estimated the excess burden per 1000 persons of the outcomes associated with COVID-19 at 6 months after T0, where excess burden was estimated by computing the difference between the average estimated survival probability from the w…”
MethodMaking Neighborhood-Disadvantage Metrics Accessible — The Neighborhood Atlas
Kind, A. J. H., & Buckingham, W. R. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1802313 · Cited by 3,310
Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation
Rubin, D. B. (2001) · Health Services and Outcomes Research Methodology · doi:10.1023/a:1020363010465 · Cited by 2,228 · cited 1×
“15 was taken as evidence of balance between the COVID-19 and VHA users group.(21,22) We estimated the excess burden per 1000 persons of the outcomes associated with COVID-19 at 6 months after T0, where excess burden was estimated by computing the difference between the average estimated survival probability from the w…”
MethodNegative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
High-dimensional characterization of post-acute sequelae of COVID-19
Al-Aly, Z., Xie, Y., & Bowe, B. (2021) · Nature · doi:10.1038/s41586-021-03553-9 · Cited by 1,518 · cited 4×
“Covariates Covariates included a set of 29 predefined potential confounders of the association between COVID-19 and adverse kidney outcomes.(1,2,15) Demographic, behavioral, and contextual characteristics included age, Area Deprivation Index, race, sex, and smoking status.”
BackgroundMethodInfluentialNeighborhood Socioeconomic Disadvantage and 30-Day Rehospitalization: A Retrospective Cohort Study
Kind, A. J. H., Jencks, S., Brock, J., Yu, M., Bartels, C., Ehlenbach, W., Greenberg, C., & Smith, M. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2946 · Cited by 1,379
Schneeweiss, S., Rassen, J. A., Glynn, R. J., Avorn, J., Mogun, H., & Brookhart, M. A. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a663cc · Cited by 1,128
Levey, A. S., & Stevens, L. A. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.02.337 · Cited by 1,005
Preoperative Renal Risk Stratification
Chertow, G. M., Lazarus, J. M., Christiansen, C. L., Cook, E. F., Hammermeister, K. E., Grover, F., & Daley, J. (1997) · Circulation · doi:10.1161/01.cir.95.4.878 · Cited by 801
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
Delorey, T. M., Ziegler, C. G. K., Heimberg, G., Normand, R., Yang, Y., Segerstolpe, Å., Abbondanza, D., Fleming, S. J., Subramanian, A., Montoro, D. T., et al. (2021) · Nature · doi:10.1038/s41586-021-03570-8 · Cited by 794
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
Daugherty, S. E., Guo, Y., Heath, K., Dasmariñas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., & Cohen, K. (2021) · BMJ · doi:10.1136/bmj.n1098 · Cited by 435
Burden of Cause-Specific Mortality Associated With PM 2.5 Air Pollution in the United States
Bowe, B., Xie, Y., Yan, Y., & Al-Aly, Z. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.15834 · Cited by 367
Self-citationXie, Y., Bowe, B., Yan, Y., Xian, H., Li, T., & Al-Aly, Z. (2019) · BMJ · doi:10.1136/bmj.l1580 · Cited by 228
Self-citationThe Inflammatory Cascade in Acute Ischemic Renal Failure
Okusa, M. D. (2002) · Nephron · doi:10.1159/000049032 · Cited by 222
Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19
Bowe, B., Cai, M., Xie, Y., Gibson, A. K., Maddukuri, G., & Al-Aly, Z. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09610620 · Cited by 208
Self-citationHigher blood urea nitrogen is associated with increased risk of incident diabetes mellitus
Xie, Y., Bowe, B., Li, T., Xian, H., Yan, Y., & Al-Aly, Z. (2018) · Kidney International · doi:10.1016/j.kint.2017.08.033 · Cited by 197
Self-citationXie, Y., Bowe, B. C., Gibson, A. K., McGill, J. B., Maddukuri, G. S., Yan, Y., & Al‐Aly, Z. (2020) · Diabetes Care · doi:10.2337/dc20-1890 · Cited by 166
Self-citationAl‐Aly, Z., Maddukuri, G. S., & Xie, Y. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.07.012 · Cited by 159
Self-citationProton pump inhibitors and acute kidney injury: a nested case–control study
Klepser, D. G., Collier, D. S., & Cochran, G. L. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-150 · Cited by 128
Knipe, D. W., Evans, H. E. R., Marchant, A. L., Gunnell, D., & John, A. M. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15870.1 · Cited by 109
Bowe, B. C., Xie, Y., Gibson, A. K., Cai, M., van Donkelaar, A., Martin, R. V., Burnett, R. T., & Al‐Aly, Z. (2021) · Environment International · doi:10.1016/j.envint.2021.106564 · Cited by 104
Self-citationLeonard, C. E., Freeman, C. P., Newcomb, C. W., Reese, P. P., Herlim, M., Bilker, W. B., Hennessy, S., & Strom, B. L. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3329 · Cited by 100
Covid-19: Mental health consequences of pandemic need urgent research, paper advises
Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m1515 · Cited by 91
Raker, E. J., Zacher, M. L., & Lowe, S. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006706117 · Cited by 88
Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD
Bowe, B. C., Xie, Y., Xian, H., Li, T., & Al‐Aly, Z. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09710916 · Cited by 77
Self-citationGeographic Variation and US County Characteristics Associated With Rapid Kidney Function Decline
Bowe, B. C., Xie, Y., Xian, H., Lian, M., & Al‐Aly, Z. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.08.016 · Cited by 54
Self-citationXie, Y., Bowe, B. C., Gibson, A. K., McGill, J. B., Maddukuri, G. S., & Al‐Aly, Z. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.2488 · Cited by 54
Self-citationXie, Y., Bowe, B. C., Gibson, A. K., McGill, J. B., Yan, Y., Maddukuri, G. S., & Al‐Aly, Z. (2020) · Diabetes Care · doi:10.2337/dc20-1231 · Cited by 41
Self-citationCOVID-19 policies in the UK and consequences for mental health
Townsend, E. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30457-0 · Cited by 26
Distinguishing between direct and indirect consequences of covid-19
Figueroa, J. D., Brennan, P. M., Τheodoratou, E., Poon, M. T. C., Purshouse, K. R., Din, F. V. N., Jin, K., Mesa‐Eguiagaray, I., Dunlop, M. G., Hall, P. S., et al. (2020) · BMJ · doi:10.1136/bmj.m2377 · Cited by 24
County-Level Contextual Characteristics and Disparities in Life Expectancy
Xie, Y., Bowe, B. C., Yan, Y., Cai, M., & Al‐Aly, Z. (2021) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.043 · Cited by 20
Self-citation
Cited by
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Long-term cardiovascular outcomes of COVID-19
Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-01689-3 · Cited by 2,029
Self-citationLong COVID after breakthrough SARS-CoV-2 infection
Al-Aly, Z., Bowe, B., & Xie, Y. (2022) · Nature Medicine · doi:10.1038/s41591-022-01840-0 · Cited by 866
Self-citationAcute and postacute sequelae associated with SARS-CoV-2 reinfection
Bowe, B., Xie, Y., & Al-Aly, Z. (2022) · Nature Medicine · doi:10.1038/s41591-022-02051-3 · Cited by 639
Self-citationLong COVID science, research and policy
Al-Aly, Z., Davis, H., McCorkell, L., Soares, L., Wulf-Hanson, S., Iwasaki, A., & Topol, E. J. (2024) · Nature Medicine · doi:10.1038/s41591-024-03173-6 · Cited by 538
Self-citation
Metadata
- Authors
- Bowe, B., Xie, Y., Xu, E., & Al-Aly, Z.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2021-11
- Volume
- 32
- Issue
- 11
- Pages
- 2851-2862
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W3196529166
- Cited by
- 333
- References
- 31
- FWCI
- 26.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.